argenx announces U.S. FDA label expansion for VYVGART, VYVGART Hytrulo to include all adult generalized myasthenia gravis regardless of serotype
https://finviz.com/quote?t=ARGX&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.